CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned

MeSH terms

• Antineoplastic Agents, Hormonal / therapeutic use*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / enzymology*
• Breast Neoplasms / epidemiology*
• Breast Neoplasms / prevention & control*
• Cytochrome P-450 CYP2D6 / genetics*
• Female
• Glucuronosyltransferase / genetics*
• Humans
• Letrozole
• Neoplasm Recurrence, Local / epidemiology*
• Neoplasm Recurrence, Local / prevention & control*
• Nitriles / therapeutic use*
• Polymorphism, Single Nucleotide*
• Postmenopause*
• Tamoxifen / therapeutic use*
• Triazoles / therapeutic use*